CompletedNot Applicable

The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"

France1,011 participantsStarted 2009-11

Plain-language summary

The purpose of this study is to determine: * Condition of intensive care unit (ICU) admission in patients with haematological malignancies. * ICU hospital and up to one year mortality. * Assessment of post ICU burden and health related quality at 90-d and 1 year.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hematological malignancies * hospitalization in ICU * age \>= 18 years Exclusion Criteria: * Patients who have already participated to TRIAL-OH

What they're measuring

Survival status at one year

Timeframe: 1 year

Trial details

NCT IDNCT01172132

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2011-05

View on ClinicalTrials.gov More Hematological Malignancies trials